Cipla share will remain in focus on Thursday ... Afrezza is a rapid-acting insulin delivered through an inhaler as compared to current insulins which are given as injections.

Cipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the ...

In 1978, Cipla started manufacturing of Metered-Dose Inhaler (MDI). 1984 was the year when the company name was changed from The Chemical, Industrial & Pharmaceutical Laboratories to Cipla Limited.

Drugmaker Cipla expects its “diversified” business in the US to help sustain its growth ... On the new US administration’s possible tariffs on pharmaceuticals, Vohra said, the company had invested ...

Pharmaceutical giant Cipla on January 28 reported a consolidated net profit of Rs 1,571 crore for the quarter ended on December 31. This marks a 49 percent rise from the Rs 1,056 crore net profit ...

It has also notified extension of separate ceiling price of IV fluids in special packaging and separate ceiling price for Cipla's Synchrobreathe inhaler, following a latest Authority meeting. The ...

Cipla share price today: The pharma major reported a 49% increase in net profit, reaching Rs 1,571 crore (Image: Reuters) Motilal Oswal has maintained a Neutral rating on Cipla, with a target ...